Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Convalescent Plasma Therapy for Covid-19: Lessons From Sars-Cov, Mers-Cov, and H1n1 Infection Pubmed



Hosseini P1 ; Rahimi H2 ; Najafabadi MM3 ; Ghorbani A4, 10 ; Najafabadi SK5 ; Faridzadeh A6, 11 ; Arabpour J7 ; Khormali E8 ; Deravi N9
Authors

Source: Acta Medica Indonesiana Published:2021


Abstract

The global widespread mortality after the emergence of SARS-CoV-2 infection in China, has become a critical concern all around the world. Convalescent plasma (CP) therapy is one of the methods elevating the survival rate for COVID-19 infection cases. This technique, as a practicable therapy, was used in previous viral outbreaks including influenza, SARS and MERS. In CP therapy, the blood plasma is collected from persons rehabilitated from that specific infection in order to develop a passive immunity in other patients. Therefore, this review aimed to point out the role of CP therapy in aforementioned viral infections and illustrate different factors influencing the efficacy of CP therapy. © 2021, Indonesian Society of Internal Medicine. All rights reserved.
Related Docs
View other Related Docs
1. Convalescent Plasma Against Covid-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases, Microorganisms (2020)
2. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
3. Immunological Effects of Convalescent Plasma Therapy for Coronavirus: A Scoping Review, BMC Infectious Diseases (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Saeed Mohammadi (3)
Other Related Docs
4. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
5. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
6. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
7. Potential Therapeutic Options for Covid-19: An Update on Current Evidence, European Journal of Medical Research (2022)
8. Convalescent Plasma Therapy in Patients With Severe Covid-19, a Single-Arm, Retrospective Study, Microbial Pathogenesis (2022)
9. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
10. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
11. The Effectiveness of Convalescent Plasma Administered on the First Day of Admission for Covid-19 Patients: An Open-Label Randomized Controlled Trial, Infectious Diseases and Immunity (2025)
12. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
13. Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions, Advances in Experimental Medicine and Biology (2021)
14. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
15. The Demographic and Serological Characteristics of Covid-19 Convalescent Plasma Donors: Identification of Basic Criteria for Optimal Donor Selection, Transfusion and Apheresis Science (2022)
16. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
17. Ubiquitous Convalescent Plasma: An Artificial Universal Plasma for Covid-19 Patients, Transfusion and Apheresis Science (2021)
18. Early High-Titer Convalescent Plasma Therapy in Patients With Moderate and Severe Covid-19, Transfusion and Apheresis Science (2022)
19. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
20. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)